Format

Send to

Choose Destination
Methods Mol Biol. 2019;1872:211-222. doi: 10.1007/978-1-4939-8823-5_20.

Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method.

Author information

1
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
2
ARUP Laboratories, Salt Lake City, UT, USA.
3
Department of Pathology, University of Utah, Salt Lake City, UT, USA. gwen.mcmillin@aruplab.com.
4
ARUP Laboratories, Salt Lake City, UT, USA. gwen.mcmillin@aruplab.com.

Abstract

In utero exposure to cannabis may cause various short- and long-term health problems in newborns, such as low birth weight and neonatal withdrawal syndrome. Drug testing with umbilical cord tissue can be used to identify in utero exposure to cannabis. Here, we described a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method that simultaneously quantifies four cannabinoids in umbilical cord tissue, including tetrahydrocannabinol (THC), 11-nor-Δ9-carboxy-THC (THC-COOH), cannabinol (CBN), and 11-hydroxy-THC (11-OH-THC). Umbilical cord specimens are weighed and homogenized, and cannabinoids are extracted using anion exchange solid-phase extraction columns (AX-SPE). Liquid chromatography separation is performed, and quantitative results are obtained using LC-MS/MS.

KEYWORDS:

11-OH-THC; CBN; Cannabis exposure; LC-MS/MS; THC; THC-COOH; Umbilical cord

PMID:
30350293
DOI:
10.1007/978-1-4939-8823-5_20
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center